The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.

about

Effects of crystallographic and geometric orientation on ion beam sputtering of gold nanorods.

P2860

Q48263273-92ED00A4-AE9A-48AB-9768-0C7EAEC4ED45

P2860

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q41455781

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Potential of Heavy-Ion The ...... ed Non-Small Cell Lung Cancer.

@en

type

Item

label

The Potential of Heavy-Ion The ...... ed Non-Small Cell Lung Cancer.

@en

prefLabel

The Potential of Heavy-Ion The ...... ed Non-Small Cell Lung Cancer.

@en

P1476

The Potential of Heavy-Ion The ...... ced Non-Small Cell Lung Cancer

@en

P2093

David R Grosshans

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

Quynh-Nhu Nguyen

http://www.w3.org/2001/XMLSchema#string

Radhe Mohan

http://www.w3.org/2001/XMLSchema#string

Stephen M Hahn

http://www.w3.org/2001/XMLSchema#string

Steven J Frank

http://www.w3.org/2001/XMLSchema#string

Timothy D Solberg

http://www.w3.org/2001/XMLSchema#string

Zhongxing Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Charged particles in radiation oncology.

Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells.

Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial

Charged particle therapy--optimization, challenges and future directions.

The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.

Reply to D. Ball et al.

P304

201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2017.00201

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen G Chun

Charles B Simone

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28929085

http://www.w3.org/2001/XMLSchema#string

P932

5591826

http://www.w3.org/2001/XMLSchema#string

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.

about

P2860

P2860

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932